Excedrin Extra Strength
- Product NDC
- 66715-9810
- Requested package NDC
- 66715-9810-2
- 11-digit product format
- 667159810
- Labeler code
- 66715
- Product ID
- 66715-9810_458c59d3-e231-99ac-e063-6394a90ac131
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen, Aspirin, and Caffeine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Lil Drug Store Products, Inc
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2010-05-10
- Substance
- ACETAMINOPHEN; ASPIRIN; CAFFEINE
- Active strength
- 250; 250; 65 mg/1; mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Excedrin Extra Strength
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 250 mg/1 |
| ASPIRIN | 250 mg/1 |
| CAFFEINE | 65 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3G6A5W338E | Internal UNII lookup |
| R16CO5Y76E | Internal UNII lookup |
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7f0f8b3c-c226-4a3a-af46-a708f345e4f5 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66715-9810-2 | Excedrin Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 10 | |
| 66715-9810-2 | Excedrin Extra Strength | 2 in 1 CARTON | TABLET, FILM COATED | 2 | 10 | |
| 66715-9810-3 | Excedrin Extra Strength | 3 in 1 CARTON | TABLET, FILM COATED | 3 | 10 | |
| 66715-9810-3 | Excedrin Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 10 | |
| 66715-9810-7 | Excedrin Extra Strength | 25 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 25 | 10 | |
| 66715-9810-7 | Excedrin Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 10 | |
| 66715-9810-8 | Excedrin Extra Strength | 30 in 1 CARTON | TABLET, FILM COATED | 30 | 10 | |
| 66715-9810-8 | Excedrin Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 66715-9810 | EXCEDRIN EXTRA STRENGTH (ACETAMINOPHEN, ASPIRIN, AND CAFFEINE) TABLET, FILM COATED EXCEDRIN EXTRA STRENGTH, TRAVEL BASIX (ACETAMINOPHEN, ASPIRIN, AND CAFFEINE) TABLET, FILM COATED EXCEDRIN EXTRA STRENGTH, CVP HEALTH (ACETAMINOPHEN, ASPIRIN, AND CAFFEINE) TABLET, FILM COATED [LIL DRUG STORE PRODUCTS, INC] | 9 | Current NDC, Legacy NDC, 8 package rows | 20241127_7f0f8b3c-c226-4a3a-af46-a708f345e4f5.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Childrens Chewables | ACETAMINOPHEN | Strategic Sourcing Services LLC | af2cbbaf-9b73-440a-bc88-a790cafccc6b | 2026-10-28 | Warnings | M013 |
| Aspirin | ASPIRIN | Walgreen Company | 82cc404b-fcf5-4e48-ab1a-09d8c47f9e04 | 2026-10-27 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | REMEDYREPACK INC. | 05618d62-ebec-4d30-989d-999891977e0e | 2026-10-27 | Warnings | M013 |
| Tension Headache Relief | ACETAMINOPHEN AND CAFFEINE | HHH Pharmaceuticals | 0ba50950-2e6e-4337-a776-b19ac988feca | 2026-10-27 | Warnings | M013 |
| ASPIRIN | ASPIRIN | Marc Glassman, Inc. | 14cb1d2d-95b8-447e-8d79-e6ec82c0e431 | 2026-10-27 | Warnings | M013 |
| GoodMeds Acetaminophen Rapid Release | ACETAMINOPHEN RAPID RELEASE | Cabinet Health P.B.C. | 5ed756b6-dbab-e742-e063-6294a90a27f3 | 2026-10-27 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | PD-Rx Pharmaceuticals, Inc. | da7d95af-6583-429d-8d04-e0424f32e9ad | 2026-10-27 | Warnings | M013 |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | WALGREENS | 07d34e7a-c0c6-f3c4-e063-6294a90aa5c3 | 2026-10-26 | Warnings | M013 |
| Aspirin | ASPIRIN | Marlex Pharmaceuticals Inc. | cc7013ea-cf30-6f59-e053-2a95a90a1148 | 2026-10-26 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | PD-Rx Pharmaceuticals, Inc. | 3f96aeb1-a533-4d36-9a1f-62fc094b6754 | 2026-10-26 | Warnings | M013 |
| Acetaminophen PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | FOODHOLD U.S.A., LLC | fdd7ce80-d6be-41b9-affd-d024cf306b50 | 2026-10-26 | Warnings | M013 |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | CVS Pharmacy | 9e459853-5951-4ae7-88a6-85b502e9dd41 | 2026-10-26 | Warnings | M013 |
| Bayer Genuine Aspirin | ASPIRIN | Select Consumer Group | 3ca776c2-47ed-5107-e063-6394a90ac5df | 2026-10-24 | Warnings | M013 |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | Select Consumer Group | 3caa0a47-de83-90d2-e063-6394a90a3436 | 2026-10-24 | Warnings | M013 |
| Aspi-Cor | ASPIRIN | L.N.K. International, Inc. | 9f919a48-ffd8-49fa-b6fd-ec71cc12e64b | 2026-10-23 | Warnings | M013 |
| Aspirin Enteric Coated, Regular Strength | ASPIRIN | Walgreen Company | 5e1484d3-5be1-40da-a3bf-fb19f7d27d45 | 2026-10-23 | Warnings | M013 |
| MAX relief junior Grape | CHILDRENS ACETAMINOPHEN | Atlantic Biologicals Corp. | 5e38af7c-f5f3-6e5c-e063-6294a90a1772 | 2026-10-23 | Warnings | M013 |
| Acetaminophen Extra Strength | ACETAMINOPHEN | CVS PHARMACY | 64a1ebe7-af28-4b09-96e8-28fa4dcc52bd | 2026-10-23 | Warnings | M013 |
| Genexa Kids Pain and Fever | ACETAMINOPHEN | Genexa Inc. | 5130c695-a80e-2dd3-e063-6294a90a404f | 2026-10-22 | Warnings | M013 |
| Tension Headache Relief | ACETAMINOPHEN, CAFFEINE | Pioneer Life Sciences, LLC | ac9efd62-8fee-b777-e053-2995a90a3783 | 2026-10-21 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | PSN | 7f0f8b3c-c226-4a3a-af46-a708f345e4f5 | 10 |
| 209468 | EXCEDRIN 250 MG / 250 MG / 65 MG Oral Tablet | PSN | 7f0f8b3c-c226-4a3a-af46-a708f345e4f5 | 10 |
| 209468 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin] | SBD | 7f0f8b3c-c226-4a3a-af46-a708f345e4f5 | 10 |
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | SCD | 7f0f8b3c-c226-4a3a-af46-a708f345e4f5 | 10 |
| 308297 | APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet | SY | 7f0f8b3c-c226-4a3a-af46-a708f345e4f5 | 10 |
| 209468 | APAP 250 MG / ASA 250 MG / Caffeine 65 MG Oral Tablet [Excedrin] | SY | 7f0f8b3c-c226-4a3a-af46-a708f345e4f5 | 10 |
| 209468 | Excedrin Extra Strength (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet | SY | 7f0f8b3c-c226-4a3a-af46-a708f345e4f5 | 10 |
| 209468 | Excedrin Menstrual Complete (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet | SY | 7f0f8b3c-c226-4a3a-af46-a708f345e4f5 | 10 |
| 209468 | Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet | SY | 7f0f8b3c-c226-4a3a-af46-a708f345e4f5 | 10 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 66715-9810-2 | 66715981002 | 2 POUCH in 1 CARTON (66715-9810-2) / 2 TABLET, FILM COATED in 1 POUCH | 2 pouch | 2016-02-04 | 0000-00-00 | No | No | Current |